Page 85 - 《中国药房》2023年24期

2021，16（1）：143. et al. Humanistic burden of problem joints for children
[35] JOHNSTON K，STOFFMAN J M，MICKLE A T，et al. and adults with haemophilia[J]. Haemophilia，2023，29
Preferences and health-related quality-of-life related to （2）：608-618.
disease and treatment features for patients with hemo‐ [47] BENJAMIN K，VERNON M K，PATRICK D L，et al.
philia A in a Canadian general population sample[J]. Pa‐ Patient-reported outcome and observer-reported outcome
tient Prefer Adherence，2021，15：1407-1417. assessment in rare disease clinical trials：an ISPOR COA
[36] O’HARA J，MARTIN A P，NUGENT D，et al. Evidence emerging good practices task force report[J]. Value
of a disability paradox in patient-reported outcomes in Health，2017，20（7）：838-855.
haemophilia[J]. Haemophilia，2021，27（2）：245-252. [48] 连小赟，李魁星，华宝来，等. 北京地区单中心成人重型
[37] OLDENBURG J，TRAN H，PEYVANDI F，et al. Health- 血友病 A 患者的三级预防治疗[J]. 中国医学科学院学
related quality of life and health status in adolescent and 报，2015，37（4）：398-401.
adult people with haemophilia A without factor Ⅷ inhibi‐ LIAN X Y，LI K X，HUA B L，et al. Low-dose tertiary
tors：a non-interventional study[J]. Haemophilia，2021，27 prophylactic therapy for severe haemophilia A adults in A
（3）：398-407. single medical center in Beijing area[J]. Acta Acad Med
[38] XU R H，DONG D，LUO N，et al. Evaluating the psycho‐ Sin，2015，37（4）：398-401.
metric properties of the EQ-5D-5L and SF-6D among pa‐ [49] 林艾灵，谭宝滢，宣建伟，等. 成人血友病A 患者预防治
tients with haemophilia[J]. Eur J Health Econ，2021，22 疗的多维度价值综述[J]. 中国卫生经济，2023，42（4）：
（4）：547-557. 61-64.
[39] NIU J Y，NING L W，ZHANG Q，et al. Health-related LIN A L，TAN B Y，XUAN J W，et al. A review on the
quality of life of patients with haemophilia：a cross- multidimensional value of prophylactic treatment in adult
sectional survey in the Northeast of China[J]. BMJ Open， hemophilia A patients[J]. Chin Health Econ，2023，42（4）：
2022，12（2）：e056668. 61-64.
[40] RODRIGUEZ-SANTANA I， DASMAHAPATRA P， [50] MANCO-JOHNSON M J，SOUCIE J M，GILL J C. Pro‐
BURKE T，et al. Health-related quality of life，direct phylaxis usage，bleeding rates，and joint outcomes of he‐
medical and societal costs among children with moderate mophilia，1999 to 2010：a surveillance project[J]. Blood，
or severe haemophilia in Europe：multivariable models of 2017，129（17）：2368-2374.
the CHESS-PAEDs study[J]. Orphanet J Rare Dis，2022， [51] 吴洁琪，曹林林，孙利华. EQ-5D和SF-6D测量同期健康
17（1）：150. 效用值的比较研究[J]. 卫生经济研究，2020，37（2）：
[41] RODRIGUEZ-SANTANA I， DASMAHAPATRA P， 42-45.
BURKE T，et al. Differential humanistic and economic WU J Q，CAO L L，SUN L H. Comparative study of EQ-
burden of mild，moderate and severe haemophilia in 5D and SF-6D in measuring health utility value over the
European adults：a regression analysis of the CHESS Ⅱ same period[J]. Health Econ Res，2020，37（2）：42-45.
study[J]. Orphanet J Rare Dis，2022，17（1）：148. [52] 李顺平，吴晶，陈钢. 多属性健康效用量表研制与应用述
[42] SHAIKH A，PEDRA G，CAWSON M，et al. Examining 评[J]. 中国卫生经济，2020，39（10）：5-8.
the impact of haemophilia treatment on health-related LI S P，WU J，CHEN G. Review of development and ap‐
quality of life[J]. Haemophilia，2022，28（5）：796-805. plication of multi-attribute utility instruments[J]. Chin
[43] STEEN CARLSSON K，WINDING B，ASTERMARK J， Health Econ，2020，39（10）：5-8.
et al. Pain，depression and anxiety in people with haemo‐ [53] WANG H，CAO C Q，GUO C H，et al. An evaluation of
philia from three Nordic countries：cross-sectional survey EQ-5D-3L health utility scores using five country-specific
data from the MIND study[J]. Haemophilia，2022，28（4）： tariffs in a rural population aged 45-69 years in Hua
557-567. county，Henan Province，China[J]. Health Qual Life Out‐
[44] XU R H，DONG D，LUO N，et al. Mapping the haem-A- comes，2020，18（1）：228.
QoL to the EQ-5D-5L in patients with hemophilia[J]. [54] 李顺平，窦蕾，房云海. 中国血友病药物经济学评价研究
Qual Life Res，2022，31（5）：1533-1544. 的现状与展望[J]. 罕见病研究，2022，1（4）：468-473.
[45] ZHANG W H，XIE S T，XUE F，et al. Health-related qua- LI S P，DOU L，FANG Y H. Current situation and pro-
lity of life among adults with haemophilia in China：a spect of pharmacoeconomic evaluation of hemophilia in
comparison with age-matched general population[J]. Hae‐ China[J]. J Rare Dis，2022，1（4）：468-473.
mophilia，2022，28（5）：776-783. （收稿日期：2023-07-24 修回日期：2023-11-23）
[46] BURKE T，RODRIGUEZ-SANTANA I，CHOWDARY P， （编辑：孙 冰）

中国药房 2023年第34卷第24期 China Pharmacy 2023 Vol. 34 No. 24 · 3019 ·